KEY TAKEAWAYS Nvidia is reportedly expanding in China, even as the U.S. cracks down on its sale of chips to the country.The Financial Times reported Friday that the U.S. chip firm is building a ... ( read original story ...)
Fierce Pharma Asia—Pfizer partner’s trial win; Roche’s $300M China plant; Hengrui’s HK IPO plan
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | Pfizer and RemeGen's HER2 ADC delivered positive phase 3 results in a bladder ... ( read original story ...)
Nvidia says it is not sending GPU designs to China after reports of new Shanghai operation
Nvidia said it won't be sending GPU plans to China following a report that the artificial intelligence chipmaker is working on a research and development center in Shanghai in light of recent U.S. ( read original story ...)
Nvidia plans China research centre as export curbs bite: Report
SHANGHAI: US chipmaker Nvidia is planning to build a research and development centre in Shanghai, the Financial Times reported on Friday (May 16), as tighter export restrictions imposed by Washington ... ( read original story ...)
Nvidia plans R&D center in Shanghai to keep foothold strong – report
Nvidia (NASDAQ:NVDA) is planning to establish a new R&D center in Shanghai in a bid to grow its presence in the Chinese market, ... ( read original story ...)
Cops warn of scammers using spoofed 52 Division phone line to trick victims
Take names. Hang up. Call the police directly. That was the advice from Toronto Police after they alerted the public about a spike in fraudulent phone calls where scammers are impersonating officers ... ( read original story ...)
Billion-dollar Hong Kong IPOs keep coming as China’s biggest drug company joins rush
Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge. ( read original story ...)